International Biotechnology Trust Plc (IBT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2020 | 08-2019 | 08-2018 | 08-2017 | 08-2016 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 2,455 | -2,566 | 2,786 | 6,406 | 5,214 |
| Other Working Capital | -62,976 | 24,012 | -3,790 | -30,541 | 28,684 |
| Other Operating Activity | 50,969 | -14,974 | 17,174 | 38,846 | -12,429 |
| Operating Cash Flow | $-9,552 | $6,472 | $16,170 | $14,711 | $21,469 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,572 | 5,262 | N/A | N/A | N/A |
| Common Stock Repurchased | -1,131 | N/A | 0 | -616 | -11,624 |
| Dividend Paid | -9,547 | -10,616 | -10,138 | -8,636 | N/A |
| Financing Cash Flow | $-9,106 | $-5,354 | $-10,138 | $-9,252 | $-11,624 |
| Beginning Cash Position | 886 | -232 | -6,264 | -11,723 | -21,568 |
| End Cash Position | -17,772 | 886 | -232 | -6,264 | -11,723 |
| Net Cash Flow | $-18,658 | $1,118 | $6,032 | $5,459 | $9,845 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,552 | 6,472 | 16,170 | 14,711 | 21,469 |
| Free Cash Flow | -9,552 | 6,472 | 16,170 | 14,711 | 21,469 |